
lymphomahub.com
Dec 20, 2024, 01:00
Ahmed Kotb: Mantle Cell Lymphoma Risk Stratification and Case Insights from ASH24
Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company (KFSHI), shared a post on X:
“Mantle Cell Lymphoma (MCL): Risk Stratification and Case Insights
- Clinical: MIPI score (Age, LDH, PS, WBC).
- Biologic: Ki-67 >30% aggressive disease.
- Genetics: TP53 mutations (poor prognosis), complex karyotype, NOTCH1.”
More posts featuring Ahmed Kotb.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 15:06
Feb 21, 2025, 14:27
Feb 21, 2025, 14:13
Feb 21, 2025, 13:29